Jump to section
To advance science and human health by providing researchers with a new and powerful method of cellular analysis.
11% employee growth in 12 months
LevitasBio is a biotechnology company dedicated to advancing human health by developing a platform for cellular analysis. Its magnetic levitation technology detects, quantifies, separates, and tests cells. The solution can be used in therapy, diagnostics, and research areas.
With Levitas, technology researchers can speed up their workflow to separate cells in minutes instead of hours. This offers new opportunities for discovery in oncology, bacteriology and immunology research. The company has also turned its attentions to developing next generation sample processing and characterization protocols, to fight the bottleneck caused by the numerous pre-processing steps needed to be able to analyze complex biological samples.
The company has raised significant funding towards expanding its portfolio and applications, with the ultimate goal of accelerating its commercial success. With its novel, next-gen products, and applications in various high-profile research projects, LevitasBio has positioned itself to lead cell-sample analysis into the future.
Freddie
Company Specialist at Welcome to the Jungle
Nov 2022
$35m
SERIES C
Jan 2021
$18m
SERIES B
Utkan Demirci
(Co-founder)Previously worked at Harvard Medical School for 6 years, holding various positions such as Assistant Professor and Associate Professor of Medicine. Co-founded DxNow and Koek Biotechnology.
Gozde Durmus
(Co-founder)Earned a PhD in Biomedical Engineering from Brown University. Worked for 7 years at Stanford University, first as Postdoctoral Research Fellow for 5 years and then as Assistant Professor for 2 years.